Carregant...
Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer
Purpose: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have been...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5688917/ https://ncbi.nlm.nih.gov/pubmed/29151951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.21783 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|